Skip to main content
. 2022 Oct 4;11(19):5863. doi: 10.3390/jcm11195863

Figure 4.

Figure 4

The prognostic value of the BBB score in the TCGA cohort (A) and subgroups defined by WHO grade (BD). The association between GSVA scores of all stromal cells in the glioma TME with clinical outcome (E) and BBB score had the most robust predictive and discriminative power for median survival time (F) and WHO grade (G) of TCGA glioma patients.